Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart sensors could help Parkinson's patients spend less time 'Off'

NCT ID NCT07074119

First seen Jan 07, 2026 · Last updated Jun 20, 2026 · Updated 27 times

Summary

This study tests whether wearable body sensors can help doctors better adjust medication for people with Parkinson's disease who experience motor fluctuations. 218 participants will wear the sensors for 7 days before each visit, and only the experimental group's data will guide treatment changes. The goal is to reduce the daily time spent in the 'OFF' state (when symptoms return) over 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE(PD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre d'investigations cliniques Pitié-Salpêtrière University Hospital

    Paris, Île-de-France Region, 75013, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

wearable body-worn sensors (BWS) for monitoring motor symptoms

What this could lead to

If successful, this could provide a new, data-driven way for doctors to fine-tune Parkinson's medication remotely, reducing time spent with poor symptom control.

What could go wrong

This is an early-stage study with no prior randomized evidence for this approach. The sensors may not capture real-life conditions accurately, and results may not lead to widespread use.

Conditions

The condition(s) this trial relates to.

Dyskinesias Hypokinesia Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.